Sign in
Taking people in United StatesNo phase

Studies Health Outcomes and Causes of Uterine Birth Differences

Observes women with uterine differences present from birth, examining cancer links and possible causes.

Key facts

Who runs it
Yale University
Where
New Haven, United StatesSee the site
Trial code
Registry title
Congenital Uterine Anomalies: Identifying Cancer Associations and Genetic and Environmental Factors to Improve Clinical Care
Status
Recruiting
People taking part
300 people, planned
Started
14 Jul 2021
Expected to end
Aug 2027
Type of study
Observational
Record updated
9 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for females aged 13 or older who have a congenital uterine anomaly, a difference in the shape of the uterus present from birth. It studies health outcomes, cancer links, and genetic and environmental causes.

Age
13 years or older
Sex
Females only
Disease stage
A diagnosis of any variation of congenital uterine anomaly (CUA).

Main reasons for not taking part

  • Declines to take part when contacted
  • Non-English speaking, except Spanish speaking
  • Unable to take part in the consent or assent process due to mental disability
  • Care not received at Yale New Haven Hospital, Bridgeport Hospital, Greenwich Hospital or Lawrence+ Memorial Hospital

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • females
  • age: 13 or older
  • encounters limited to: Yale New Haven Hospital, Bridgeport Hospital, Greenwich Hospital and Lawrence+ Memorial Hospital
  • diagnosis of any variation of CUA

Who cannot take part

  • who will decline to participate in a study upon contact
  • non-English speaking except Spanish speaking
  • unable to participate in consent or assent process due to mental disability

This trial is currently available in United States.

  • Yale UniversityNew Haven, United StatesContact: Monica G Konstantino, RNTaking people

About the trial

What the trial wants to find out

The purpose of this research study is to learn more about the health outcomes associated with congenital uterine anomalies (CUAs), and the possible environmental and genetic causes of the condition. The researchers plan to investigate whether any cancer associations (with breast, renal, ovarian, vaginal and uterine cancers) exist in females with CUAs. The investigator will also investigate any environmental and genetic factors that may be responsible for causing CUAs.

The group in the trial

  • Patients with Congenital Uterine Anomalies (CUA)

    The rates of renal, breast, uterine, ovarian and vaginal cancers in women who have been diagnosed with a CUA will be studies

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Congenital Uterine Anomalies: Identifying Cancer Associations and Genetic and Environmental Factors to Improve Clinical Care
Plain-language title
Studies Health Outcomes and Causes of Uterine Birth DifferencesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
9 June 2026